Eiko Lifesciences has announced the financial results for the quarter.

The company's Board of Directors approved the unaudited standalone and consolidated results.

For the standalone performance, Total Income from Operations stood at ₹0.81 Cr, with a Net Profit after tax of ₹0.69 Cr, and Basic EPS at ₹0.50. On a consolidated basis, Total Income reached ₹1.01 Cr, Net Profit after tax was ₹1.12 Cr, and Basic EPS stood at ₹0.66. These figures provide a clear look into the company's recent operational and financial health, crucial for shareholders.